scholarly journals Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases

Theranostics ◽  
2021 ◽  
Vol 11 (14) ◽  
pp. 7018-7028
Author(s):  
De-Shen Wang ◽  
Hui Yang ◽  
Xiao-Yun Liu ◽  
Zhi-Gang Chen ◽  
Yun Wang ◽  
...  
Keyword(s):  
Adjuvant Chemotherapy ◽  
Liver Metastases ◽  
Colorectal Liver Metastases ◽  
Circulating Tumor Dna ◽  
Dynamic Monitoring ◽  
Tumor Dna

scholarly journals Circulating Tumor DNA as Surveillance Following Resection of Colorectal Liver Metastases - Results from a Prospective Single Center Trial

HPB ◽  
2021 ◽  
Vol 23 ◽  
pp. S18-S19
Author(s):  
A.R. Knudsen ◽  
M.Ø. Larsen ◽  
M. Meier ◽  
L.M.S. Petersen ◽  
F.V. Mortensen ◽  
...  
Keyword(s):  
Liver Metastases ◽  
Colorectal Liver Metastases ◽  
Circulating Tumor Dna ◽  
Single Center ◽  
Tumor Dna

scholarly journals Circulating tumor DNA for prognosis assessment and postoperative management after curative‐intent resection of colorectal liver metastases

2022 ◽  
Author(s):  
Thomas Reinert ◽  
Lena Marie Skindhøj Petersen ◽  
Tenna Vesterman Henriksen ◽  
Marie Øbo Larsen ◽  
Mads Heilskov Rasmussen ◽  
...  
Keyword(s):  
Liver Metastases ◽  
Colorectal Liver Metastases ◽  
Circulating Tumor Dna ◽  
Postoperative Management ◽  
Curative Intent ◽  
Tumor Dna

scholarly journals Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer

2019 ◽  
Vol 30 (9) ◽  
pp. 1472-1478 ◽  
Author(s):  
B. Lee ◽  
L. Lipton ◽  
J. Cohen ◽  
J. Tie ◽  
A.A. Javed ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Adjuvant Chemotherapy ◽  
Circulating Tumor Dna ◽  
Potential Marker ◽  
Tumor Dna

Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases—a Japanese Nationwide Survey

2019 ◽  
Vol 24 (6) ◽  
pp. 1244-1260 ◽  
Author(s):  
Shin Kobayashi ◽  
Toru Beppu ◽  
Goro Honda ◽  
Masakazu Yamamoto ◽  
Keiichi Takahashi ◽  
...  
Keyword(s):  
Adjuvant Chemotherapy ◽  
Liver Metastases ◽  
Survival Benefit ◽  
Colorectal Liver Metastases ◽  
Nationwide Survey

Is There a Survival Benefit to Neoadjuvant Versus Adjuvant Chemotherapy, Combined with Surgery for Resectable Colorectal Liver Metastases?

2009 ◽  
Vol 33 (5) ◽  
pp. 1028-1034 ◽  
Author(s):  
Nir Lubezky ◽  
Ravit Geva ◽  
Einat Shmueli ◽  
Richard Nakache ◽  
Joseph M. Klausner ◽  
...  
Keyword(s):  
Adjuvant Chemotherapy ◽  
Liver Metastases ◽  
Survival Benefit ◽  
Colorectal Liver Metastases
Sign in / Sign up

Export Citation Format

Share Document